BMEZ (BlackRock Health Sciences Term Trust) Research & Development: $0.0 Mil (TTM As of Dec. 2025)


BMEZ BlackRock Health Sciences Term Trust BMEZ
39 GF Score
Price $15.71
! 4 Warning Signs
View Full Analysis

What is BlackRock Health Sciences Term Trust Research & Development?

BlackRock Health Sciences Term Trust BMEZ +1.88% 39 Research & Development is $0.0 Mil as of Dec. 2025. GuruFocus rates BMEZ with a GF Score™ of 39/100. The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. BlackRock Health Sciences Term Trust's Research & Development for the six months ended in Dec. 2025 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $0.0 Mil.

BlackRock Health Sciences Term Trust  (NYSE:BMEZ) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

BlackRock Health Sciences Term Trust Research & Development Related Terms

BlackRock Health Sciences Term Trust Research & Development Historical Data

* Premium members only.

The historical data trend for BlackRock Health Sciences Term Trust's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BlackRock Health Sciences Term Trust Research & Development Chart

BlackRock Health Sciences Term Trust Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

BlackRock Health Sciences Term Trust Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BMEZ
39GF Score
BlackRock Health Sciences Term Trust BMEZ
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BlackRock Health Sciences Term Trust Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.0 Mil mean?
BlackRock Health Sciences Term Trust (BMEZ) has a Research & Development of $0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on BlackRock Health Sciences Term Trust and its competitors.
Is BlackRock Health Sciences Term Trust's Research & Development too high?
BlackRock Health Sciences Term Trust's current Research & Development is $0.0 Mil. Overall, BlackRock Health Sciences Term Trust has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does BlackRock Health Sciences Term Trust's Research & Development compare to BTZ and AIO?
BlackRock Health Sciences Term Trust's Research & Development of $0.0 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on BlackRock Health Sciences Term Trust and its competitors. BlackRock Health Sciences Term Trust's current Research & Development is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BlackRock Health Sciences Term Trust stock overvalued right now?
BlackRock Health Sciences Term Trust (BMEZ) has a current Research & Development of $0.0 Mil. The current Research & Development is $0.0 Mil. BlackRock Health Sciences Term Trust's overall GF Score™ is 39/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For BlackRock Health Sciences Term Trust (BMEZ), the current Research & Development is $0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BlackRock Health Sciences Term Trust Business Description

Address 100 Bellevue Parkway, Wilmington, DE, USA, 19809
BlackRock Health Sciences Term Trust is a closed-end fund focused on the healthcare and health sciences sector. Its investment objectives are to provide total return and income through long-term capital appreciation.
39GF Score

Get the complete analysis for BMEZ

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.71
Price